Keyphrases
Neurodegenerative Diseases
100%
Autoimmune Disease
100%
Glatiramer Acetate
100%
Copolymer-1
100%
Dual Action
100%
Protective Autoimmunity
50%
Neurodegeneration
25%
Protective Effect
25%
Vaccination
25%
Inflammatory Response
25%
Multiple Sclerosis Treatment
25%
Autoreactive T Cells
25%
Defense Mechanisms
25%
Approved Drugs
25%
Therapeutic Vaccine
25%
Body Defence
25%
Medicine and Dentistry
Neurodegenerative Disorder
100%
Glatiramer
100%
Autoimmune Disease
60%
Protective Autoimmunity
40%
Serositis
20%
Neurodegeneration
20%
T Cell
20%
Degenerative Disease
20%
Immunity
20%
Treatment of Multiple Sclerosis
20%
Therapeutic Vaccine
20%
Immunology and Microbiology
Glatiramer Acetate
100%
Autoimmune Disease
60%
Autoimmunity
40%
T Cell
20%
Immunity
20%
Treatment of Multiple Sclerosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glatiramer
100%
Autoimmune Disease
60%
Nerve Degeneration
20%
Inflammation
20%
Degenerative Disease
20%
Multiple Sclerosis
20%
Therapeutic Vaccine
20%